FFA
TEVA icon

First Foundation Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

First Foundation Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-24,510
Closed -$378K – 380
2018
Q4 		$378K Buy
+24,510
New +$502K 0.02% 294
2017
Q3 		– Sell
-105,803
Closed -$3.52M – 335
2017
Q2 		$3.52M Buy
105,803
+8,674
+9% +$268K 0.21% 70
2017
Q1 		$3.12M Buy
97,129
+6,406
+7% +$219K 0.19% 75
2016
Q4 		$3.29M Sell
90,723
-25,932
-22% -$1.04M 0.22% 80
2016
Q3 		$5.37M Buy
116,655
+3,072
+3% +$160K 0.37% 53
2016
Q2 		$5.71M Buy
113,583
+13,298
+13% +$708K 0.41% 55
2016
Q1 		$5.37M Buy
100,285
+30,956
+45% +$1.82M 0.39% 57
2015
Q4 		$4.55M Sell
69,329
-24,501
-26% -$1.51M 0.31% 67
2015
Q3 		$5.3M Buy
93,830
+41,872
+81% +$2.71M 0.44% 55
2015
Q2 		$3.07M Buy
51,958
+12,061
+30% +$744K 0.24% 65
2015
Q1 		$2.49M Buy
39,897
+4,818
+14% +$280K 0.21% 65
2014
Q4 		$2.02M Buy
35,079
+3,710
+12% +$207K 0.18% 71
2014
Q3 		$1.69M Buy
31,369
+6,002
+24% +$318K 0.17% 64
2014
Q2 		$1.33M Buy
25,367
+5,897
+30% +$301K 0.15% 65
2014
Q1 		$1.03M Buy
19,470
+1,255
+7% +$58K 0.13% 62
2013
Q4 		$730K Sell
18,215
-285,713
-94% -$11.3M 0.1% 73
2013
Q3 		$11.5M Buy
303,928
+11,740
+4% +$458K 1.79% 25
2013
Q2 		$11.5M Buy
+292,188
New +$11.4M 2.24% 20

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Foundation Advisors's TEVA Position: Q1 2019 in Review

First Foundation Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2019, closing a stake of 24,510 shares — an estimated $378K sold.

First Foundation Advisors first reported a position in TEVA in Q2 2013 and held it in 18 quarters. The position peaked at $11.5M in Q3 2013. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • First Foundation Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2019 after selling out during the quarter.
  • First Foundation Advisors sold 24,510 Teva Pharmaceutical Industries Limited shares in Q1 2019, an estimated $378K.
  • First Foundation Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 18 quarters.
  • First Foundation Advisors's Teva Pharmaceutical Industries Limited position peaked at $11.5M in Q3 2013.
  • 522 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2019.

Based on First Foundation Advisors's 13F filing for Q1 2019, filed 13 May 2019.